Advertisement

Aprea Therapeutics, Inc. APRE

Set alert

Price alert · APRE

All alert types
0.48 USD -0.01 -1.82%

At close · Oct 30

0.48 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
0.48 × 2
Ask
0.51 × 2
0.46 Day range 0.5214
0.449 52-week range 1.45
YTD
-43.19%
1 year
-66.58%
Open
0.4788
Prev close
0.4936
Mkt cap
6.10M
Vol
167.61K
Avg vol
308.29K
EPS
-0.95
P/E
0.00
Div yield
0.00%
More statistics
Low
0.46
High
0.5214
Forward P/E
-3.08
Beta
1.74
Short ratio
0.55
Inst. own
43.85%
Dividend
0.00
Ex-div date
Earnings
Aug 12, 2024
50-d avg
3.48
200-d avg
4.17
1y target
15.67

5D chart

Chart tools
Interval

Signals (116)
NameTimeAgo
SMA: BearishOct 30, 9:30 AM1 day ago
SMA: BearishOct 30, 9:30 AM1 day ago
MACD: Sell SignalOct 30, 9:30 AM1 day ago
RSI: OversoldOct 30, 9:30 AM1 day ago
SMA: BullishOct 29, 3:55 PM2 days ago
SMA: BullishOct 29, 3:15 PM2 days ago
MACD: Buy SignalOct 29, 3:15 PM2 days ago
SMA: BearishOct 29, 2:25 PM2 days ago
SMA: BullishOct 29, 2:20 PM2 days ago
MACD: Sell SignalOct 29, 2:10 PM2 days ago
SMA: BearishOct 29, 1:55 PM2 days ago
SMA: BearishOct 29, 1:55 PM2 days ago
SMA: BullishOct 29, 1:35 PM2 days ago
SMA: BearishOct 29, 1:20 PM2 days ago
SMA: BullishOct 29, 1:15 PM2 days ago
MACD: Buy SignalOct 29, 12:55 PM2 days ago
SMA: BullishOct 29, 12:50 PM2 days ago
MACD: Sell SignalOct 29, 12:15 PM2 days ago
SMA: BearishOct 29, 12:00 PM2 days ago
SMA: BearishOct 29, 12:00 PM2 days ago
SMA: BullishOct 29, 11:50 AM2 days ago
SMA: BullishOct 29, 11:50 AM2 days ago
SMA: BearishOct 29, 11:45 AM2 days ago
MACD: Buy SignalOct 29, 11:10 AM2 days ago
SMA: BullishOct 29, 11:05 AM2 days ago
RSI: OversoldOct 29, 10:40 AM2 days ago
RSI: OversoldOct 29, 9:55 AM2 days ago
SMA: BearishOct 29, 9:30 AM2 days ago
SMA: BearishOct 29, 9:30 AM2 days ago
SMA: BullishOct 28, 3:55 PM3 days ago
SMA: BullishOct 28, 3:40 PM3 days ago
SMA: BearishOct 28, 3:35 PM3 days ago
SMA: BearishOct 28, 3:35 PM3 days ago
SMA: BullishOct 28, 3:30 PM3 days ago
MACD: Sell SignalOct 28, 3:00 PM3 days ago
SMA: BearishOct 28, 2:55 PM3 days ago
SMA: BullishOct 28, 2:50 PM3 days ago
SMA: BearishOct 28, 2:45 PM3 days ago
SMA: BullishOct 28, 2:20 PM3 days ago
SMA: BullishOct 28, 2:20 PM3 days ago
MACD: Buy SignalOct 28, 2:20 PM3 days ago
MACD: Sell SignalOct 28, 1:45 PM3 days ago
SMA: BearishOct 28, 1:40 PM3 days ago
SMA: BearishOct 28, 1:40 PM3 days ago
SMA: BullishOct 28, 1:25 PM3 days ago
MACD: Buy SignalOct 28, 1:25 PM3 days ago
RSI: OverboughtOct 28, 1:25 PM3 days ago
MACD: Sell SignalOct 28, 12:45 PM3 days ago
SMA: BearishOct 28, 12:40 PM3 days ago
MACD: Buy SignalOct 28, 12:20 PM3 days ago
SMA: BullishOct 28, 12:05 PM3 days ago
MACD: Sell SignalOct 28, 11:25 AM3 days ago
SMA: BearishOct 28, 11:20 AM3 days ago
MACD: Buy SignalOct 28, 11:00 AM3 days ago
SMA: BullishOct 28, 10:50 AM3 days ago
SMA: BullishOct 28, 10:50 AM3 days ago
SMA: BearishOct 28, 10:35 AM3 days ago
SMA: BearishOct 28, 10:35 AM3 days ago
MACD: Sell SignalOct 28, 10:35 AM3 days ago
MACD: Buy SignalOct 28, 10:20 AM3 days ago
SMA: BullishOct 28, 10:10 AM3 days ago
SMA: BullishOct 28, 10:10 AM3 days ago
SMA: BearishOct 28, 9:45 AM3 days ago
SMA: BearishOct 27, 3:45 PM4 days ago
MACD: Sell SignalOct 27, 3:45 PM4 days ago
SMA: BullishOct 27, 3:35 PM4 days ago
RSI: OverboughtOct 27, 3:35 PM4 days ago
SMA: BearishOct 27, 3:30 PM4 days ago
RSI: OverboughtOct 27, 2:35 PM4 days ago
MACD: Buy SignalOct 27, 2:10 PM4 days ago
RSI: OverboughtOct 27, 2:10 PM4 days ago
SMA: BullishOct 27, 1:55 PM4 days ago
SMA: BullishOct 27, 1:55 PM4 days ago
SMA: BearishOct 27, 1:35 PM4 days ago
SMA: BearishOct 27, 1:15 PM4 days ago
MACD: Sell SignalOct 27, 1:05 PM4 days ago
MACD: Buy SignalOct 27, 12:30 PM4 days ago
SMA: BullishOct 27, 12:10 PM4 days ago
SMA: BullishOct 27, 12:10 PM4 days ago
SMA: BearishOct 27, 12:05 PM4 days ago
SMA: BearishOct 27, 11:50 AM4 days ago
SMA: BullishOct 27, 11:30 AM4 days ago
SMA: BearishOct 27, 11:25 AM4 days ago
MACD: Sell SignalOct 27, 11:25 AM4 days ago
MACD: Buy SignalOct 27, 11:20 AM4 days ago
RSI: OverboughtOct 27, 11:20 AM4 days ago
SMA: BullishOct 27, 10:55 AM4 days ago
MACD: Sell SignalOct 27, 10:40 AM4 days ago
SMA: BearishOct 27, 10:25 AM4 days ago
SMA: BullishOct 27, 9:30 AM4 days ago
SMA: BullishOct 27, 9:30 AM4 days ago
MACD: Buy SignalOct 27, 9:30 AM4 days ago
SMA: BearishOct 26, 3:55 PM5 days ago
MACD: Sell SignalOct 26, 3:55 PM5 days ago
SMA: BullishOct 26, 3:40 PM5 days ago
SMA: BearishOct 26, 3:30 PM5 days ago
SMA: BearishOct 26, 3:30 PM5 days ago
SMA: BullishOct 26, 3:05 PM5 days ago
MACD: Buy SignalOct 26, 3:00 PM5 days ago
SMA: BullishOct 26, 2:50 PM5 days ago
SMA: BearishOct 26, 2:30 PM5 days ago
SMA: BullishOct 26, 2:25 PM5 days ago
SMA: BearishOct 26, 2:20 PM5 days ago
SMA: BullishOct 26, 2:15 PM5 days ago
SMA: BearishOct 26, 1:55 PM5 days ago
SMA: BearishOct 26, 1:55 PM5 days ago
SMA: BullishOct 26, 1:45 PM5 days ago
SMA: BullishOct 26, 1:30 PM5 days ago
SMA: BearishOct 26, 1:15 PM5 days ago
SMA: BearishOct 26, 1:15 PM5 days ago
MACD: Sell SignalOct 26, 1:15 PM5 days ago
SMA: BullishOct 26, 12:00 PM5 days ago
SMA: BullishOct 26, 11:35 AM5 days ago
RSI: OversoldOct 26, 11:15 AM5 days ago
SMA: BearishOct 26, 11:10 AM5 days ago
SMA: BullishOct 26, 10:35 AM5 days ago

Key statistics

Market cap
17.07M
Enterprise value
-5.20M
Trailing P/E
0.00
Forward P/E
-3.08
PEG ratio
0.00
Price / sales
13.38
Price / book
0.69
EPS (TTM)
-2.80
Beta
1.74
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
1.28M
Revenue growth
124.90%
Free cash flow
-9.36M
Total cash
28.69M
Total debt
0
Return on equity
-50.11%
Shares outstanding
5.43M
Short % of float
0.38%
50-day average
3.48
200-day average
4.17

Analyst view

Consensus: buy

Buy
Price target (mean) 15.67 +3132.9% upside
Target (low)
11.00
Target (mean)
15.67
Target (high)
20.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Aug 12, 2024

Expected Aug 12, 2024. Consensus EPS estimate -0.57.

Earnings history

Financials — quick view

All financials
APRE Revenue — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
APRE Net income — quarterly -3.59M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
APRE EPS — quarterly -0.07
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

APRE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-0.75-0.64+0.11+14.67%
Aug 12, 2024Jun 1, 2024-0.64-0.58+0.06+9.38%
Aug 12, 2024Jun 1, 2024-0.64———
May 14, 2024Mar 1, 2024-0.78———
May 14, 2024Mar 1, 2024-0.78-0.67+0.11+14.10%
Mar 26, 2024Dec 1, 2023-0.56-0.92-0.36-64.29%

Upgrades / downgrades

APRE analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.reitBuyBuy
Nov 18, 2024HC Wainwright & Co.reitBuyBuy
Oct 24, 2024HC Wainwright & Co.reitBuyBuy
Aug 13, 2024WedbushreitOutperformOutperform
Aug 12, 2024HC Wainwright & Co.reitBuyBuy
Jun 24, 2024HC Wainwright & Co.reitBuyBuy

About Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
aprea.com

News

Your note

Sign in to keep a note on APRE — it syncs with the Stock Master app.

Insider holders

APRE insider holders
InsiderRelationLatest transactionDateShares held
DUEY MARCDirectorSaleOct 17, 2024234,253
GILAD OREN PH.D.Chief Executive OfficerPurchaseOct 22, 2024335,195
GRISSINGER MICHAEL J.DirectorStock Award(Grant)Jun 19, 20241,844
HAMILL JOHN PChief Financial OfficerPurchaseOct 10, 202419,368
HENNEMAN JOHN BELL IIIDirectorStock Award(Grant)Jun 19, 20249,184
MIRZA NADEEM Q.OfficerStock Award(Grant)Apr 30, 20246,730

Institution ownership

APRE institution ownership
Holder% heldSharesValueReported
AIGH Capital Management LLC9.92%539,3001.69MSep 29, 2024
Sio Capital Management, LLC5.09%276,603868.53KSep 29, 2024
Sphera Funds Management Ltd.4.97%270,000847.80KSep 29, 2024
Nantahala Capital Management, LLC3.79%205,760646.09KSep 29, 2024
Vanguard Group Inc3.20%173,842545.86KSep 29, 2024
Stonepine Capital Management, LLC2.52%137,174430.73KSep 29, 2024

Fund ownership

APRE fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.67%145,280456.18KSep 29, 2024
Vanguard Extended Market Index Fund0.53%28,56289.68KSep 29, 2024
Fidelity Extended Market Index Fund0.47%25,27579.36KOct 30, 2024
Fidelity Total Market Index Fund0.13%7,19722.60KOct 30, 2024
Fidelity Series Total Market Index Fund0.11%5,96318.72KOct 30, 2024
Dimensional ETF Tr-Dimensional U.S. Targeted Value ETF0.09%5,08315.96KJul 30, 2024
Advertisement